Back to top
more

Centene (CNC)

(Real Time Quote from BATS)

$25.70 USD

25.70
5,910,735

+0.44 (1.74%)

Updated Aug 8, 2025 02:02 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (231 out of 244)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.

Zacks Equity Research

Why Should You Retain Centene (CNC) Stock in Your Portfolio?

by Zacks Equity Research

Banking on a rising revenue base and an inorganic growth strategy, Centene (CNC) holds enough potential to reap benefits for investors.

Zacks Equity Research

Centene (CNC) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Centene (CNC) closed at $45.39 in the latest trading session, marking a +1.11% move from the prior day.

Zacks Equity Research

Zacks Market Edge Highlights: UnitedHealth, Centene, MasTec, Bank of America and Bristol-Myers Squibb

by Zacks Equity Research

Zacks Market Edge Highlights: UnitedHealth, Centene, MasTec, Bank of America and Bristol-Myers Squibb

Tracey Ryniec headshot

Could the Trade War be Bullish for Stocks?

by Tracey Ryniec

Tariffs, tweets, negotiations, the Fed cutting rates, full employment, a manufacturing slowdown: how investors can cut through the noise.

Zacks Equity Research

Why Anthem (ANTM) is an Attractive Pick for Your Portfolio

by Zacks Equity Research

Riding high on strategic buyouts, partnerships and a strong revenue flow, Anthem (ANTM) holds potential to reap benefits for investors.

Zacks Equity Research

Centene's Unit, Canopy Health Extend Ties to Improve Care

by Zacks Equity Research

Centene's (CNC) subsidiary Health Net extends collaboration with Canopy Health to cater wider reach to its CaIPERS members.

Zacks Equity Research

Should Value Investors Buy Centene (CNC) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Centene (CNC) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Centene (CNC) closed at $46.14 in the latest trading session, marking a +1.16% move from the prior day.

Zacks Equity Research

Centene (CNC) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Centene (CNC) closed at $45.36, marking a +0.73% move from the previous day.

Zacks Equity Research

Ensign Group (ENSG) Up 33.2% in a Year: More Room for Rally?

by Zacks Equity Research

Ensign Group's (ENSG) revenue stream and strategic initiatives should bolster revenue growth. This will likely support its share price going forward.

Zacks Equity Research

Why Is Centene (CNC) Down 12.7% Since Last Earnings Report?

by Zacks Equity Research

Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Centene (CNC) Moves to Buy: Rationale Behind the Upgrade

by Zacks Equity Research

Centene (CNC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Equity Research

Should Value Investors Consider Centene (CNC) Stock Now?

by Zacks Equity Research

Let's see if Centene (CNC) stock is a good choice for value-oriented investors right now from multiple angles.

Zacks Equity Research

Molina Healthcare's Arm Joins Abarca for Better Medical Care

by Zacks Equity Research

Molina Healthcare's (MOH) subsidiary collaborates with Abarca to enable its members to easily avail Medication Therapy Management services.

Zacks Equity Research

Why is It Worth Holding Humana (HUM) in Your Portfolio?

by Zacks Equity Research

Banking high on its strong Medicare business and strategic buyouts, Humana (HUM) shows potential to reap benefits for investors, partly offset by high costs.

Zacks Equity Research

Centene Expands Existence in Health Insurance Marketplace

by Zacks Equity Research

Centene (CNC) to increase offerings in the 2020 Health Insurance Marketplace across 10 U.S. state markets.

Zacks Equity Research

Is Centene (CNC) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

3 Reasons Growth Investors Will Love Centene (CNC)

by Zacks Equity Research

Centene (CNC) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Equity Research

Zacks.com featured highlights include: Inter Parfums, Glu Mobile, Centene, Fortinet and Remark Media

by Zacks Equity Research

Zacks.com featured highlights include: Inter Parfums, Glu Mobile, Centene, Fortinet and Remark Media

Zacks Equity Research

Zacks Industry Outlook Highlights: Joint, Anthem, Centene and UnitedHealth

by Zacks Equity Research

Zacks Industry Outlook Highlights: Joint, Anthem, Centene and UnitedHealth

Sanghamitra Saha headshot

Bet on Rising P/E Stocks to Enjoy Solid Gains

by Sanghamitra Saha

Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

Sapna Bagaria headshot

Outlook for Health Insurance Industry Looks Sanguine

by Sapna Bagaria

Consolidation, increasing senior population, technological advancements and development of supplementary healthcare businesses poise the health insurance industry for secular growth.

Zacks Equity Research

Community Health's (CYH) Q2 Loss Widens, Revenues Fall Y/Y

by Zacks Equity Research

Community Health's (CYH) second-quarter results suffer due to lower admissions.

Zacks Equity Research

Tenet Healthcare (THC) Q2 Earnings Top Estimates & Rise Y/Y

by Zacks Equity Research

Tenet Healthcare's (THC) second-quarter earnings gain on the back of its Hospital and Other segment and volume growth.

Zacks Equity Research

Ensign Group's (ENSG) Q2 Earnings Beat Estimates, Rise Y/Y

by Zacks Equity Research

Ensign Group's (ENSG) second-quarter earnings gain traction from improved revenues.